BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Bdb Chembl4574620

2+ PubMed studies analyzed · Evidence Score: 6.7

Research Domains

Bdb Chembl4574620 has been studied across 1 research domains including 🔬 Oncology. The primary research focus is 🔬 Oncology with 50% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bdb Chembl4574620, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

gw632580x
3 shared targets
selitrectinib
3 shared targets
larotrectinib
3 shared targets
repotrectinib
3 shared targets
sns
3 shared targets
naporafenib
2 shared targets
merestinib
3 shared targets
purvalanol
2 shared targets
bms
4 shared targets
lorlatinib
3 shared targets
Loading evidence profile...

This evidence profile for Bdb Chembl4574620 is generated deterministically from 2 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.